| abstract |
Long term exposure to volatile organic components (VOCs) has been linked to chronic diseases, conditions and symptoms such as diseases of the blood vessels, heart and/or lung: psychiatric disorders, diseases of the nervous system and genetic diseases, among others. Methods and products are disclosed to treat chronically ill patients as well as healthy patients to reduce or eliminate exposure to VOCs. |